Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.

导出 OA

翻译打印收藏纠错

第一作者： Kah-Whye,Peng

第一单位： Vyriad Inc, Rochester MN 55901, USA; Imanis Life Sciences, Rochester MN 55901, USA; Department of Molecular Medicine, Mayo Clinic, MN 55905, USA.

作者： Kah-Whye,Peng ^[1] ; Timothy,Carey ^[2] ; Patrycja,Lech ^[2] ; Rianna,Vandergaast ^[2] ; Miguel Á,Muñoz-Alía ^[3] ; Nandakumar,Packiriswamy ^[3] ; Clement,Gnanadurai ^[2] ; Karina,Krotova ^[2] ; Mulu,Tesfay ^[2] ; Christopher,Ziegler ^[2] ; Michelle,Haselton ^[2] ; Kara,Sevola ^[2] ; Chase,Lathrum ^[2] ; Samantha,Reiter ^[2] ; Riya,Narjari ^[2] ; Baskar,Balakrishnan ^[3] ; Lukkana,Suksanpaisan ^[2] ; Toshie,Sakuma ^[2] ; Jordan,Recker ^[4] ; Lianwen,Zhang ^[3] ; Scott,Waniger ^[4] ; Luke,Russell ^[4] ; Christopher D,Petro ^[5] ; Christos A,Kyratsous ^[5] ; Alina,Baum ^[5] ; Jody L,Janecek ^[6] ; Rachael M,Lee ^[6] ; Sabarinathan,Ramachandran ^[6] ; Melanie L,Graham ^[6] ; Stephen J,Russell ^[7]

作者单位： Vyriad Inc, Rochester MN 55901, USA; Imanis Life Sciences, Rochester MN 55901, USA; Department of Molecular Medicine, Mayo Clinic, MN 55905, USA. ^[1] Imanis Life Sciences, Rochester MN 55901, USA. ^[2] Department of Molecular Medicine, Mayo Clinic, MN 55905, USA. ^[3] Vyriad Inc, Rochester MN 55901, USA. ^[4] Regeneron Pharmaceuticals Inc, Tarrytown, NY 10591, USA. ^[5] Department of Surgery, University of Minnesota, USA. ^[6] Vyriad Inc, Rochester MN 55901, USA; Imanis Life Sciences, Rochester MN 55901, USA; Department of Molecular Medicine, Mayo Clinic, MN 55905, USA. Electronic address: sjrussell@vyriad.com. ^[7]

关键词 Neutralizing antibodies Oral vaccine Rhabdovirus SARS-CoV-2 T cells VSV